ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1278

Nature and Severity of Activity Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Functional Disability

Manja van Wissen1, Maaike gademan1, Cornelia van den Ende2, Max Teuwen1, Wilfred Peter1, Dirkjan van Schaardenburg3, Alfons den Broeder2, Thea Vliet Vlieland4 and Salima van Weely1, 1Leiden University Medical Center, Leiden, Netherlands, 2Sint Maartenskliniek, Nijmegen, Netherlands, 3Reade, Amsterdam, Netherlands, 4Leids University Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2023

Keywords: Comorbidity, Disability, Health Assessment Questionnaire (HAQ), physical function, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 13, 2023

Title: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Not withstanding modern treatment, some Rheumatoid Arthritis (RA) patients have severe disability due to persistently high disease activity, joint destruction/deformities and/or comorbidities. Insight into the severity and nature of their functional limitations is important to treat this subgroup adequately. The aim of this research was to describe the severity and nature of functional limitations in RA patients with severe functional limitations, according to the Health Assessment Questionnaire Disability Index (HAQ-DI).

Methods: Baseline data from RA patients with severe functional limitations participating in a randomized controlled trial on the (cost-)effectiveness of longstanding physical therapy compared to usual care were used (Netherlands Trial Register NL8238). Participants completed the HAQ-DI, a questionnaire reflecting problems in activities of daily living and consisting of 20 items divided over eight domains (Dressing and grooming, Arising, Eating, Walking, Personal hygiene, Reaching, Gripping and Usual activities). Each item is scored on a 4-point scale (0-3, no difficulty-unable to perform), with the total HAQ-DI score ranging from 0-3 (no disability-severe disability). Demographic characteristics were administered and the EuroQol 5-Dimensions 5-Levels (EQ-5D-5L, index score (-0.446-1.000), and Visual Analogue Scale (EQ-VAS, 0-100)) were used to estimate health-related quality of life.

Results: 215 participants were included (n=194; 90% women, age 58.8 (SD 12.9) years, median disease duration 19 (IQR 9-27) years). The median EQ-5D-5L index and EQ-VAS were 0.6 (0.3-0.7) and 59 (41 -70). The median total HAQ-DI score was 1.5 (1.1-1.9) and the majority (83%, n=179) had a total HAQ-DI score ≥1, indicating moderate to severe functional limitations. Figure 1 shows the mean HAQ-DI scores per domain and the percentage of patients reporting no/some/much difficulty or inability to perform daily activities within each domain. More than half of the participants had a domain score ≥1 in all 8 domains (52%, n=111), 24% (n=52) in 7 domains, 13% (n=28) in 6 domains and 11% (n=24) in 5 or less domains. The domains Personal hygiene and Reaching had the highest percentage of participants with a maximum score of 3 (42% and 28%).

Conclusion: In this subgroup of RA patients with severe functional limitations, the majority had limitations in almost all domains of the HAQ-DI. Mostly, limitations were seen in Personal hygiene and Reaching. In clinical practice, a comprehensive assessment of all areas of daily activities might thus be warranted, as well as shared decision-making between patients and clinicians to prioritize functional limitations and set personalized treatment goals.

Supporting image 1

Figure 1. Mean HAQ-DI scores for each HAQ-DI domain and the percentage of patients that reported to have either no/some/much difficulty or unable to perform everyday activities represented for each domain.

Supporting image 2


Disclosures: M. van Wissen: None; M. gademan: None; C. van den Ende: None; M. Teuwen: None; W. Peter: None; D. van Schaardenburg: None; A. den Broeder: None; T. Vliet Vlieland: None; S. van Weely: None.

To cite this abstract in AMA style:

van Wissen M, gademan M, van den Ende C, Teuwen M, Peter W, van Schaardenburg D, den Broeder A, Vliet Vlieland T, van Weely S. Nature and Severity of Activity Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Functional Disability [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/nature-and-severity-of-activity-limitations-according-to-the-health-assessment-questionnaire-disability-index-in-patients-with-rheumatoid-arthritis-and-functional-disability/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nature-and-severity-of-activity-limitations-according-to-the-health-assessment-questionnaire-disability-index-in-patients-with-rheumatoid-arthritis-and-functional-disability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology